MEDP
Medpace Holdings Inc
598.10$
-4.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.4% | +8.4% | +6.9% | +8.5% | +0.8% | -9.7% | -17.2% | +11.5% | +12.7% | +7.8% | -3.4% | |
| – | +32.3% | +25.4% | +17.1% | +18.3% | -0.3% | -20.2% | -36.6% | +41.6% | +34.2% | +15.1% | -7.8% | |
| – | +157.8% | +65.8% | +25.5% | +28.6% | +1.9% | -34.1% | -89.5% | +515.9% | +74.2% | +31.3% | -23.0% | |
| – | +157.8% | +65.8% | +25.5% | +28.6% | +1.9% | -34.1% | -89.5% | +515.9% | +74.2% | +31.3% | -23.0% | |
| – | +1.9% | -6.4% | +7.9% | +3.4% | -4.8% | +0.6% | +26.7% | -1.3% | +7.8% | -1.9% | +12.0% | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -1.5% | -1.0% | -1.0% | -1.0% | -1.0% | -0.7% | -0.7% | -0.7% | -0.7% | -0.5% | -0.5% | |
| – | +8.1% | +2.4% | +2.9% | +4.0% | +6.0% | +2.2% | +7.3% | +4.3% | +3.9% | +1.0% | +6.0% | |
| – | +9.0% | +3.4% | +3.8% | +4.9% | +6.1% | +1.6% | +8.7% | +5.2% | +4.7% | +0.1% | +6.7% | |
| – | +1,344.7% | -7.0% | -91.9% | +7.7% | -1.4% | +1.7% | +5.1% | +0.1% | -6.8% | +2.7% | – | |
| – | +9.8% | -23.4% | +12.2% | -4.3% | +24.1% | +88.5% | -29.4% | -38.7% | +6.1% | +22.3% | +9.0% | |
| – | +18.7% | +20.1% | +13.7% | +15.4% | -6.3% | -28.1% | -71.0% | +70.4% | +56.3% | +30.3% | -27.5% | |
| – | – | – | – | – | -87.6% | -3,402.5% | – | – | – | – | – | |
| – | +0.2% | +0.6% | +0.3% | +0.0% | -0.2% | -2.6% | -3.3% | -1.5% | -2.5% | 0.0% | -0.7% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.